We are live on ! Find out more
SIBN icon

SI-BONE Inc
SIBN

66 hedge funds and large institutions have $225M invested in SI-BONE Inc in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

33% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 18

6% more funds holding

Funds holding: 62 → 66 (+4)

5.88% more ownership

Funds ownership: 45.53% → 51.41% (+5.9%)

1% less capital invested

Capital invested by funds: $227M → $225M (-$2.07M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
66
Holders Change
+4
Holders Change %
+6.45%
% of All Funds
1.45%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
10
Increased
24
Reduced
18
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GGHC
Gilder Gagnon Howe & Co
New York
+$12.6M
2
Morgan Stanley
Morgan Stanley
New York
+$7.37M
3
SAM
Silvercrest Asset Management
New York
+$5.67M
4
BlackRock
BlackRock
New York
+$5.34M
5
Ameriprise
Ameriprise
Minnesota
+$5M

Top Sellers

1
O
OrbiMed
New York
-$10.8M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.99M
3
NCGI
Next Century Growth Investors
Minnesota
-$1.86M
4
Millennium Management
Millennium Management
New York
-$1.73M
5
BC
Broadfin Capital
New York
-$1.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
51
Oxford Asset Management
United Kingdom
$185K +$201K +10,495 New
AIG
52
American International Group
New York
$179K -$1.34K -70 -0.7%
MIM
53
MetLife Investment Management
New Jersey
$148K – – –
Deutsche Bank
54
Deutsche Bank
Germany
$128K -$248K -12,973 -64%
PO
55
Private Ocean
California
$115K – – –
MLICM
56
Metropolitan Life Insurance Company (MetLife)
New York
$107K +$90.9K +4,744 +359%
JP Morgan Chase
57
JP Morgan Chase
New York
$93K -$817K -42,645 -89%
LF
58
Lee Financial
Texas
$65K – – –
Legal & General Group
59
Legal & General Group
United Kingdom
$47K – – –
BNP Paribas Financial Markets
60
BNP Paribas Financial Markets
France
$40.9K +$25.7K +1,344 +138%
AIP
61
Ameritas Investment Partners
Nebraska
$25K – – –
Bank of Montreal
62
Bank of Montreal
Ontario, Canada
$25K +$996 +52 +4%
Citigroup
63
Citigroup
New York
$24K -$85.4K -4,460 -77%
TRCT
64
Tower Research Capital (TRC)
New York
$21K +$22.5K +1,175 +23,500%
AF
65
Advisornet Financial
Minnesota
$5K +$5.75K +300 New
Royal Bank of Canada
66
Royal Bank of Canada
Ontario, Canada
$2K -$1.38K -72 -44%
Alyeska Investment Group
67
Alyeska Investment Group
Illinois
– -$1.99M -97,890 Closed
ECM
68
Endurant Capital Management
California
– -$1.33M -65,216 Closed
VFA
69
Valeo Financial Advisors
Indiana
– -$102K -5,000 Closed
PCM
70
Prelude Capital Management
New York
– -$26K -1,282 Closed
CWA
71
Clarus Wealth Advisors
Arizona
– -$4K -210 Closed
Fifth Third Bancorp
72
Fifth Third Bancorp
Ohio
– -$1K -59 Closed
1 2
3

SIBN Hedge Fund Activity: Q3 2019 in Review

66 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in SI-BONE Inc (SIBN) for Q3 2019, worth a combined $225M — down 0.91% from $227M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new SIBN positions and 6 closed out — a net gain of 4 holders — while 24 added to existing stakes and 18 trimmed.

The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $12.6M. The largest seller was OrbiMed, cutting an estimated $10.8M.

  • 66 institutional investors held SI-BONE Inc (SIBN) as of Q3 2019, up from 62 in Q2 2019.
  • Funds reported $225M of SI-BONE Inc stock for Q3 2019, down 0.91% quarter-over-quarter.
  • 10 funds opened new SI-BONE Inc positions in Q3 2019 and 6 closed out, a net change of +4 holders.
  • The largest SI-BONE Inc buyer in Q3 2019 was Gilder Gagnon Howe & Co, an estimated $12.6M added.
  • The largest SI-BONE Inc seller in Q3 2019 was OrbiMed, an estimated $10.8M sold.

Based on aggregated 13F filings for Q3 2019.